By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
The panel's discussion on Freshpet (FRPT) reveals a lack of consensus, with concerns about competitive moat, capital expenditure, and margin durability, despite some bullish views on the company's digital growth and valuation.
Risk: The competitive moat and capital expenditure required to maintain it, as well as the durability of margins in the face of private label pressure and potential slowdown in digital growth.
Opportunity: The potential for a re-rating of the stock if capital expenditure peaks and free cash flow turns consistently positive.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Champlain sold 1,776,396 Freshpet shares, an estimated $124.82 million trade based on quarterly average pricing.
The quarter-end position value decreased by $108.24 million, reflecting both trading activity and stock price changes.
This transaction represented 1.58% of Champlain’s 13F-reported assets under management.
After the sale, Champlain holds zero Freshpet shares, with a reported stake value of $0.
The stake was previously 1.1% of the fund’s AUM last quarter.
According to an SEC filing dated May 13, 2026, Champlain Investment Partners, LLC, sold its entire position in Freshpet (NASDAQ:FRPT) by disposing of 1,776,396 shares during the first quarter. The estimated transaction value was $124.82 million, calculated using the quarter’s average unadjusted closing price. The quarter-end value of the stake decreased by $108.24 million, reflecting both the trade and price movement.
Champlain’s full exit from Freshpet reduced the position from 1.1% of AUM last quarter to zero.
As of May 14, 2026, shares were priced at $49.34, down 36.2% over one year, underperforming the S&P 500 by 64 percentage points.
| Metric | Value | |---|---| | Revenue (TTM) | $1.14 billion | | Net income (TTM) | $200.34 million | | Market capitalization | $2.39 billion | | Price (as of market close May 14, 2026) | $49.34 |
Freshpet:
Freshpet focuses on providing minimally processed, refrigerated pet food products to health-conscious consumers, leveraging a multi-channel retail presence to drive brand visibility and customer loyalty.
It looks like Champlain first purchased Freshpet in Q1 2019, while it was around $35 or $40. The stock soared above $150 a couple of times on hype from the pandemic-aided boom and strong growth it saw at the time, but has since dropped back down below $50 as the market reeled in Freshpet’s valuation. Following this dramatic decline, it looks like Champlain is washing its hands of the stock amid its steep underperformance.
However, I’d argue that Freshpet’s valuation might finally make sense for investors interested in the stock. Briefly trading at 22 times sales following the pandemic-aided boom, Freshpet currently trades at just 13 times EBITDA. Best yet for investors, the company has been profitable for two straight years and finally reached breakeven FCF generation this year, showing an ability to streamline its operations that hadn’t been seen before.
That said, Freshpet not only manufactures its products and controls much of its refrigerated supply chain, but also provides refrigerators to its retail customers, which consistently weighs on FCF. If the company can stick the landing with its vertically integrated model, it could pay ample dividends down the road. Investors have yet to really see this pay off, though, and that may be why Champlain finally liquidated its position.
All in all, I’m not ready to give up on Freshpet, but I’m not rushing to buy shares either. I’m happy to keep it on my watch list and see if its margins continue to improve. Selling to over 16 million households -- and with its digital orders growing by 43% in its last quarter -- Freshpet could be a steal if its improving margins are here to stay.
Before you buy stock in Freshpet, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Freshpet wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $472,205! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,384,459!
Now, it’s worth noting Stock Advisor’s total average return is 999% — a market-crushing outperformance compared to 208% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of May 15, 2026. *
Josh Kohn-Lindquist has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Freshpet and Synopsys. The Motley Fool recommends EOG Resources, Nutanix, and Penumbra. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"Freshpet's transition to positive free cash flow, despite high infrastructure costs, suggests the stock is currently undervalued relative to its long-term brand equity and digital growth trajectory."
Champlain’s total exit from Freshpet (FRPT) is a classic 'capitulation' signal, but investors should look past the headline. While the 36% year-over-year decline and valuation compression are brutal, the shift to positive FCF is the real story. The article glosses over the massive capital expenditure (CapEx) required to maintain their 'fridge-in-store' model, which is the primary anchor on profitability. At 13x EBITDA, the market is pricing in perpetual operational friction. If Freshpet can sustain the 43% digital growth and scale manufacturing without further dilutive capital raises, the current $2.39 billion market cap looks like a floor, not a ceiling, for a premium consumer brand.
The strongest case against this is that Freshpet’s vertically integrated model is a 'capital trap' where the cost of maintaining the cold chain will always outpace the margin expansion from scale.
"Champlain's full liquidation after years of ownership underscores FRPT's struggle to deliver consistent FCF despite recent profitability."
Champlain's complete exit from FRPT—dumping 1.78M shares worth $125M (1.6% of AUM), down $108M quarter-end after holding since Q1 2019—signals deep skepticism on the pet food maker's post-pandemic trajectory. Shares at $49.34 sport a cheap 2.1x TTM sales ($2.39B mkt cap / $1.14B rev) and ~12x net income ($200M), but this masks fading tailwinds, persistent fridge capex dragging FCF to breakeven, and 36% 1Y decline underperforming S&P by 64pts. Champlain's rotation to high-conviction TW (2.2% AUM), PEN, EOG highlights FRPT's vulnerability in a normalizing growth environment.
Improving margins, 43% digital order growth, and expansion to 16M households could sustain FRPT's profitability inflection, justifying a re-rating from 13x EBITDA if capex discipline holds.
"Champlain's full exit at $49.34 is a disciplined rebalancing of a 23-40% gainer, not capitulation, but the durability of FRPT's margin expansion and FCF generation under capex pressure remains unproven."
Champlain's exit is being framed as capitulation, but the timing and math deserve scrutiny. A $125M sale from a $7.9B AUM fund (1.58%) is material but not panic-driven. More telling: FRPT trades 13x EBITDA with $200M net income on $1.14B revenue (17.5% margin) and positive FCF—not a value trap. The article admits Champlain bought at $35-40 and is exiting at $49.34, a 23-40% gain despite the 36% one-year decline. This reads less like 'washing hands' and more like a disciplined trim of an outperformer relative to entry. The real risk: refrigerated supply chain capex and customer acquisition costs mask whether those margins are durable or cyclical.
If Champlain—a $7.9B manager with 7-year holding history—exits entirely rather than trim, it signals conviction that FRPT's structural model (vertical integration, fridge placement, capex drag) won't generate adequate returns even at 13x EBITDA, and the margin improvement is temporary.
"The real test for FRPT is whether FCF becomes consistently positive and margins stabilize, not the size of Champlain's exit."
Champlain's Q1 2026 exit of Freshpet removes a sizable, 1.58% of AUM position entirely, a material data point but not a definitive verdict on FRPT. The move could reflect portfolio rebalancing or risk-control rather than a forecast of deteriorating fundamentals, since Champlain stuck with other consumer names and the FRPT stake was a modest share of AUM. Still, FRPT trades at rich multiples (about 22x sales, 13x EBITDA) with ongoing vertical integration costs that depress FCF; if margin gains stall or retailer terms tighten, multiple re-rating could pressure the stock. The essential question is whether FCF turns consistently positive and whether margin improvements stick.
The exit is too small to signal a thesis shift; 1.58% of AUM is not a vote of confidence, and a single quarter could simply reflect rebalancing or liquidity needs rather than a view on FRPT.
"A full liquidation by a long-term holder signals a structural breakdown in the competitive moat, not just portfolio rebalancing."
Claude, you’re misinterpreting the exit. A full liquidation after seven years isn't 'disciplined trimming'—it’s a total abandonment of the thesis. Champlain doesn't exit a 1.78M share position entirely if they see a path to long-term compounding. The real risk everyone is missing is the competitive moat: as private labels enter the fresh pet space, FRPT’s fridge-in-store advantage is becoming a liability, forcing higher marketing spend just to maintain shelf dominance against cheaper alternatives.
"ChatGPT's 22x sales multiple is wrong; FRPT is at 2.1x TTM sales, cheap if FCF sustains."
ChatGPT, your '22x sales' multiple is invented—FRPT trades at 2.1x TTM sales ($2.39B mkt cap / $1.14B rev), as Grok correctly states, not 'rich' territory. This error downplays the FCF inflection's re-rating potential to 15-18x if capex peaks. Unflagged risk: Champlain's pivot to TW (pet retail) suggests broader sector shift from premium fresh to resilient distribution amid consumer slowdown.
"Champlain's exit reflects capital reallocation, not necessarily FRPT thesis failure—the moat erosion risk is structural, not triggered by this quarter."
Grok's correction on multiples is valid—ChatGPT's 22x sales claim is unsupported. But Grok and Gemini both miss the exit's ambiguity: Champlain could be rotating capital to higher-conviction plays (TW, EOG) rather than signaling FRPT deterioration. A full exit after gains doesn't prove the thesis broke; it proves the fund found better risk-adjusted returns elsewhere. The competitive moat question Gemini raises is real, but private label pressure existed pre-exit and isn't new data.
"FRPT's margin rebound depends on ongoing capex and operating costs; without sustained FCF growth, a high multiple may not hold if growth slows or retailers demand better terms."
Grok’s 2.1x sales correction is helpful, but the key risk remains capital efficiency. Even with a 13x EBITDA multiple, FRPT’s cash flow hinges on heavy fridge capex and elevated SG&A to sustain premium placement; any deceleration in digital growth or retailer terms could stall FCF and trigger multiple compression. Champlain’s exit may signal re-evaluation of the moat—not just a shift to TW—so watch working capital and capex intensity for durability of the margin rebound.
The panel's discussion on Freshpet (FRPT) reveals a lack of consensus, with concerns about competitive moat, capital expenditure, and margin durability, despite some bullish views on the company's digital growth and valuation.
The potential for a re-rating of the stock if capital expenditure peaks and free cash flow turns consistently positive.
The competitive moat and capital expenditure required to maintain it, as well as the durability of margins in the face of private label pressure and potential slowdown in digital growth.